MAPC transplantation confers a more durable benefit than AC133+ cell transplantation in severe hind limb ischemia. (Q53305630)

From Wikidata
Jump to navigation Jump to search
scientific article published on 17 August 2010
edit
Language Label Description Also known as
English
MAPC transplantation confers a more durable benefit than AC133+ cell transplantation in severe hind limb ischemia.
scientific article published on 17 August 2010

    Statements

    MAPC transplantation confers a more durable benefit than AC133+ cell transplantation in severe hind limb ischemia (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit